Comorbidity Between Depression and Anxiety in Patients with Temporomandibular Disorders According to the Research Diagnostic Criteria for Temporomandibular Disorders

Aims: To examine the extent of depression, anxiety, somatization, and comorbidity between depression and anxiety in patients with temporomandibular disorders (TMD) by adding the Symptom Checklist-90 Revised self-report questionnaire for anxiety to the Research Diagnostic Criteria for TMD. Methods: A total of 207 Israeli TMD patients were included in this retrospective study. Data included levels of depression, anxiety, somatization, and comorbidity in the study group as a whole, in chronic pain TMD patients compared to acute pain TMD patients, and in chronic pain TMD patients according to their Graded Chronic Pain Scale score. Spearman correlation was used to assess the level of correlation between depression, anxiety, and somatization. Fisher exact test or Pearson chi-square test was used to compare the categorical variables. Results: When depression, anxiety, somatization, and comorbidity were analyzed in a multidimensional approach, there were statistically significant differences between subgroups as to depression and somatization only. No statistically significant differences were found as to anxiety and comorbidity. Conclusion: Multidimensional assessment enabled differentiation between findings of depression, anxiety, somatization, and comorbidity in subgroups of TMD patients. The findings of no statistically significant differences between subgroups of TMD patients as to anxiety and comorbidity support previous studies on TMD and anxiety, which suggest a less significant role of anxiety in chronic TMD patients as compared to depression and somatization.

anxiety; comorbidity; depression; RDC/TMD

1. Kessler RC, Chiu WT, Demler O, Ellen E, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617–627.

2. Goldberg DP, Wittchen HU, Beesdo-Baum K, Zimmermann P, Pfister H. Anxious and non-anxious forms of major depression: Familial, personality and symptom characteristics. Psychol Med 2013;1:1–12.

3. The Diagnostic and Statistical Manual of Mental Disorders, ed 5 (DSM–5). Arlington, VA: American Psychiatric Association, 2013.

4. Bener A, Al-Kazaz M, Ftoui D, Al-Harthy M, Dafeeah EE. Diagnostic overlap of depressive, anxiety, stress and somatoform disorders in primary care. Asia Pac Psychiatry 2013;5:E29–E38.

5. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990;47:849–853.

6. Häuser W, Janke KH, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011;17:621–632.

7. Bengtsson M, Sjöberg K, Candamio M, Lerman A, Ohlsson B. Anxiety in close relationships is higher and self-esteem lower in patients with irritable bowel syndrome compared to patients with inflammatory bowel disease. Eur J Intern Med 2013; 24:266–272.

8. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 2008;70:890–897.

9. Ligthart L, Gerrits MM, Boomsma DI, Penninx BW. Anxiety and depression are associated with migraine and pain in general: An investigation of the interrelationships. J Pain 2013;14:363–370.

10. Mehalick ML, Garofalo JP, Sanders CN, Gatchel RJ. Assessment of the psychological comorbidity, pathophysiological mechanisms, and treatment implications in patients with chronic orofa-cial pain. Anaplastology 2013;S2:001. doi: 10.4172/216-1173. S2-001.

11. Yap AU, Chua EK, Tan KB. Depressive symptoms in Asian TMD patients and their association with nonspecific physical symptoms reporting. J Oral Pathol Med 2004;33:305–310.

12. Garofalo JP, Gatchel RJ, Wesley AL, Ellis E 3rd. Predicting chronicity in acute temporomandibular joint disorders using the Research Diagnostic Criteria. J Am Dent Assoc 1998;129: 438–447.

13. Krishnan KR, France RD, Pelton S, McCann UD, Davidson J, Urban BJ. Chronic pain and depression. II. Symptoms of anxiety in chronic low back pain patients and their relationship to subtypes of depression. Pain 1985;22:289–294.

14. de Ornelas Maia AC, Braga Ade A, Paes F, et al. Comorbidity of depression and anxiety: Association with poor quality of life in type 1 and 2 diabetic patients. Clin Pract Epidemiol Ment Health 2013;9:136–141.

15. Dworkin SF, LeResche L. Research Diagnostic Criteria for Temporomandibular Disorders: Review, criteria, examinations andspecifications, critique. J Craniomandib Disord 1992;6:301–355.

16. List T, Dworkin SF. Comparing TMD diagnoses and clinical findings at Swedish and US TMD centers using Research Diagnostic Criteria for Temporomandibular Disorders. J Orofac Pain 1996;10:240–253.

17. Yap AU, Dworkin SF, Chua EK, List T, Tan KB, Tan HH. Prevalence of temporomandibular disorder subtypes, psychologic distress, and psychosocial dysfunction in Asian patients. J Orofac Pain 2003;17:21–28.

18. Celic´ R, Braut V, Petricevic N. Influence of depression and somatization on acute and chronic orofacial pain in patients with single or multiple TMD diagnoses. Coll Antropol 2011;35:709–713.

19. Ozdemir-Karatas M, Peker K, Balık A, Uysal O, Tuncer EB. Identifying potential predictors of pain-related disability in Turkish patients with chronic temporomandibular disorder pain. J Headache Pain 2013;14:17.

20. Manfredini D, Borella L, Favero L, Ferronato G, Guarda-Nardini L. Chronic pain severity and depression/somatization levels in TMD patients. Int J Prosthodont 2010;23:529–534.

21. Palla S. Biopsychosocial pain model crippled? J Orofac Pain 2011;25:289–290.

22. Manfredini D, Winocur E, Ahlberg J, Guarda-Nardini L, Lobbezoo F. Psychosocial impairment in temporomandibular disorders patients. RDC/TMD axis II findings from a multicentre study. J Dent 2010;38:765–772.

23. Manfredini D, Ahlberg J, Winocur E, Guarda-Nardini L, Lobbezoo F. Correlation of RDC/TMD axis I diagnoses and axis II pain-related disability. A multicenter study. Clin Oral Investig 2011;15:749–756.

24. Dworkin SF. Temporomandibular Disorder (TMD) pain–related disability found related to depression, nonspecific physical symptoms, and pain duration at 3 international sites. J Evid Based Dent Pract 2011;11:143–144.

25. Aggarwal VR, Macfarlane GJ, Farragher TM, McBeth J. Risk factors for onset of chronic oro-facial pain–results of the North Cheshire oro-facial pain prospective population study. Pain 2010;May;149:354–359.

26. Giannakopoulos NN, Keller L, Rammelsberg P, Kronmüller KT, Schmitter M. Anxiety and depression in patients with chronic tem-poromandibular pain and in controls. J Dent 2010;38:369–376.

27. Casanova-Rosado JF, Medina-Solís CE, Vallejos-Sánchez AA, Casanova-Rosado AJ, Hernández-Prado B, Avila-Burgos L. Prevalence and associated factors for temporomandibular disorders in a group of Mexican adolescents and youth adults. Clin Oral Investig 2006;10:42–49.

28. Vassend O, Krogstad BS, Dahl BL. Negative affectivity, somatic complaints, and symptoms of temporomandibular disorders. J Psychosom Res 1995;39:889–899.

29. Meldolesi G, Picardi A, Accivile E, Toraldo di Francia R, Biondi M. Personality and psychopathology in patients with temporo-mandibular joint pain–dysfunction syndrome. A controlled investigation. Psychother Psychosom 2000;69:322–328.

30. Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: A review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985;60: 615–623.

31. Mongini F, Ciccone G, Ceccarelli M, Baldi I, Ferrero L. Muscle tenderness in different types of facial pain and its relation to anxiety and depression: A cross-sectional study on 649 patients. Pain 2007;131:106–111.

32. Madland G, Feinmann C, Newman S. Factors associated with anxiety and depression in facial arthromyalgia. Pain 2000;84:225–232.

33. Manfredini D, Bandettini di Poggio A, Cantini E, Dell’Osso L, Bosco M. Mood and anxiety psychopathology and temporomandibular disorder: A spectrum approach. J Oral Rehabil 2004; 31:933–940.

34. Stockstill JW, Callahan CD. Personality hardiness, anxiety, and depression as constructs of interest in the study of temporo-mandibular disorders. J Craniomandib Disord 1991;5:129–134.

35. Marbach JJ, Lund P. Depression, anhedonia and anxiety in temporomandibular joint and other facial pain syndromes. Pain1981;11:73–84.

36. Huang GJ, LeResche L, Critchlow CW, Martin MD, Drangsholt MT. Risk factors for diagnostic subgroups of painful temporo-mandibular disorders (TMD). J Dent Res 2002;81:284–288.

37. Kino K, Sugisaki M, Haketa T, et al. The comparison between pains, difficulties in function, and associating factors of patients in subtypes of temporomandibular disorders. J Oral Rehabil 2005;32:315–325.

38. McKinney MW, Londeen TF, Turner SP, Levitt SR. Chronic TM disorder and non-TM disorder pain: A comparison of behavioral and psychological characteristics. Cranio 1990;8:40–46.

39. Gatchel RJ, Garofalo JP, Ellis E, Holt C. Major psychological disorders in acute and chronic TMD: An initial examination. J Am Dent Assoc 1996;127:1365–1370,1372,1374.

40. Anderson GC, Gonzalez YM, Ohrbach R, et al. The research diagnostic criteria for temporomandibular disorders: VI: Futuredirections. J Orofac Pain 2010;24:79–88.

41. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

42. Reiter S, Eli I, Gavish A, Winocur E. Ethnic differences in tem-poromandibular disorders between Jewish and Arab populations in Israel according to RDC/TMD evaluation. J Orofac Pain 2006;20:36–42.

43. Steinkeller M. A retrospective analysis of temporomandibular disorders: Findings among Israeli Jews: A systematic review of cases based on the RDC/TMD index [Thesis]. Submitted as part of the requirements for the Doctor of Dental Medicine, Tel Aviv University.

44. International RDC/TMD consortium. http://rdc-tmdinternational. org/

45. Derogatis LR. SCL-90-R: Administration, Scoring and Procedures Manual-II for the Revised Version (ed 3). Towson, MD: Clinical Psychometric Research, 1994.

46. Dworkin SF, Huggins KH, LeResche L, et al. Epidemiology of signs and symptoms in temporomandibular diorders: Clinical signs in cases and controls. J Am Dent Assoc 1990; 120:273–281.

47. Löwe B, Spitzer RL, Gräfe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 2004;78:131–140.

48. Ansseau M, Dierick M, Buntinkx F, et al. High prevalence of mental disorders in primary care. J Affect Disord. 2004;78:49–55.

49. Mergl R, Seidscheck I, Allgaier AK, et al. Depressive, anxiety and somatoform disorders in primary care: Prevalence and recognition. Depress Anxiety 2007;24:185–195.

50. Geulayov G, Lipsitz J, Sabar R, Gross R. Depression in prima-ry care in Israel. Isr Med Assoc J 2007;9:571–578.

51. Laufer N, Zilber N, Jecsmien P, et al. Mental disorders in primary care in Israel: Prevalence and risk factors. Soc Psychiatry Psychiatr Epidemiol 2013;48:1539–1554.

52. Marbach JJ, Lennon MC, Dohrenwend BP. Candidate risk factors for temporomandibular pain and dysfunction syndrome: psychosocial, health behavior, physical illness and injury. Pain 1988;34:139–151.

53. Hoffmann RG, Kotchen JM, Kotchen TA, Cowley T, Dasgupta M, Cowley AW Jr. Temporomandibular disorders and associated clinical comorbidities. Clin J Pain 2011;27:268–274.

54. Carlson CR, Reid KI, Curran SL, et al. Psychological and physiological parameters of masticatory muscle. Pain 1998; 76:297–307.

55. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: Relationship to somatic and psychosocial variables. Psychosom Med 2004;66:837–844.

56. Marks DM, Han C, Krulewicz S, et al. History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: Post hoc analysis from a placebo-controlled study. Prim Care Companion J Clin Psychiatry 2008;10:368–375.

57. Annagür BB, Uguz F, Apiliogullari S, Kara I, Gunduz S. Psychiatric disorders and association with quality of sleep and quality of life in patients with chronic pain: A SCID-based study. Pain Med 2014 Feb 25 [Epub ahead of print].

58. Turk DC, Rudy TE. Towards a comprehensive assessment of chronic pain patients. Behav Res Ther 1987;25:237–249.

59. Fillingim RB, Ohrbach R, Greenspan JD, et al. Potential psycho-social risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12(11 Suppl):T46–T60.

60. Dworkin SF, Sherman J, Mancl L, Ohrbach R, LeResche L, Truelove E. Reliability, validity, and clinical utility of RDC/TMD axisII scales: Depression, non-specific physical symptoms, and graded chronic pain. J Orofac Pain 2002;16:207–220.

61. Babor TF, Brown J, Del Boca FK. Validity of self-reports in applied research on addictive behaviors: Fact or fiction? Behav Assess 1990;12:5–31.

62. Pedersen G, Karterud S. Is SCL-90-R helpful for the clinician in assessing DSM-IV symptom disorders? Acta Psychiatr Scand 2004;110:215–224.

63. Kim MJ, Lim MJ, Park WK, Kho HS. Comparison between the SCL-90-R and MMPI in TMD patients with psychological problems. Oral Dis 2012;18:140–146.

64. Ohrbach R, Turner JA, Sherman JJ, et al. The research diag-nostic criteria for temporomandibular disorders. IV: Evaluation of the psychometric properties of the axis II measures. J Orofac Pain 2010;24:48–62.

65. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006;166:1092–1097.

66. Kroenke K, Spitzer RL, Williams JB. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606–613.

67. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–266.